This study found that PeV-A3 failed to activate STAT-1, STAT-2, and IRF3 signaling in cells cultured in the FBS growth medium; in contrast, these transcription factors were activated in PeV-A3-infected GBM cells with an hPL-containing medium (Figure 4). The gene discussed is STAT1; the disease is glioblastoma.